OTCM
NEGXF
Market cap32mUSD
Jan 02, Last price
0.18USD
Name
NexgenRx Inc
Chart & performance
P/E
13.99
P/B
9.67
EPS
0.02
Vol. 1Y
—
Shs. 5Y
1.96%
Rev. 5Y
10.89%
Div Yld LY
—
Div Yld TTM
—
Revenues
17m
+5.99%
Net income
1m
+109.69%
CFO
146k
-87.32%
Dividend
Aug 28, 20260.0036 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
NexgenRx, Inc. engages in the provision of administrative services only (ASO) (Self-Funded) drug, dental and extended health benefit plans supported by technology. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company was founded by Ronald Campbell Loucks in 2003 and is headquartered in Toronto, Canada.
Key people
Ronald Loucks
President, Chief Executive Officer, Director · since 2015
Kelly Ehler
Chief Financial Officer · since 2016
Andrew Munroe
Vice President - Operations · since 2024
BJ Padda
Vice President - Implementation · since 2024
Linda Brennan
Independent Director · since 2024
Thomas Corcoran
Independent Chairman of the Board · since 2006
Randy McGlynn
Independent Director · since 2018
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||